Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2546 studies found for:    (heart disease OR heart attack) AND (stroke OR clot)
Show Display Options
Rank Status Study
1 Completed
Has Results
Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial
Conditions: Heart Disease;   Stroke;   Ischemic Heart Disease;   Myocardial Infarction
Interventions: Drug: aspirin;   Drug: Warfarin
2 Recruiting Heart and Ischemic STrOke Relationship studY
Conditions: Brain Ischemia;   Acute Stroke;   Heart Diseases
Intervention:
3 Active, not recruiting A CALIBER Study: Risk Factors for Stroke, Heart Failure, and Myocardial Infarction in Atrial Fibrillation
Conditions: Atrial Fibrillation;   Heart Failure;   Stroke;   Myocardial Infarction
Intervention:
4 Completed The Effectiveness of Personalized Stroke Risk Communication
Conditions: Cardiovascular Disease;   Stroke
Interventions: Other: Personalized Heart Attack and Stroke Risk;   Other: Standard Education
5 Completed
Has Results
Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Patients With Atherosclerosis (TRA 2°P - TIMI 50) (P04737)
Conditions: Atherosclerosis;   Ischemia;   Myocardial Infarction;   Cerebrovascular Accident;   Peripheral Arterial Disease
Interventions: Drug: Vorapaxar;   Drug: Placebo
6 Completed Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
Conditions: Myocardial Infarction;   Cardiovascular Death;   Atherothrombosis;   Stroke
Interventions: Drug: Ticagrelor 90 mg;   Drug: Ticagrelor 60 mg;   Drug: Ticagrelor Placebo
7 Terminated
Has Results
Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Particpants With Acute Coronary Syndrome (TRA•CER) (Study P04736)
Conditions: Atherosclerosis;   Myocardial Ischemia;   Myocardial Infarction
Interventions: Drug: Vorapaxar;   Drug: Placebo
8 Completed Door-to-door Survey of Cardiovascular Health, Stroke and Ischemic Heart Disease in Atahualpa
Conditions: Stroke;   Ischemic Heart Disease
Intervention:
9 Completed WENBIT - Western Norway B Vitamin Intervention Trial
Conditions: Coronary Artery Disease;   Myocardial Infarction;   Cerebrovascular Stroke
Interventions: Drug: folic acid, vitamin B12 (cyanocobalamin), vitamin B6 (pyridoxine);   Drug: folic acid, vitamin B12 (cyanocobalamin);   Drug: vitamin B6 (pyridoxine);   Drug: placebo
10 Active, not recruiting The Role of Alcohol Consumption in the Aetiology of Different Cardiovascular Disease Phenotypes: a CALIBER Study
Conditions: Chronic Stable Angina;   Unstable Angina;   Coronary Heart Disease Not Otherwise Specified;   Acute Myocardial Infarction;   Heart Failure;   Ventricular Arrhythmias;   Cardiac Arrest;   Abdominal Aortic Aneurysm;   Peripheral Arterial Disease;   Ischaemic Stroke;   Subarachnoid Haemorrhagic Stroke;   Intracerebral Haemorrhagic Stroke;   Stroke Not Otherwise Specified;   Sudden Cardiac Death;   Unheralded Coronary Death;   Mortality;   Coronary Heart Disease (CHD);   Cardiovascular Disease (CVD);   Fatal Cardiovascular Disease (Fatal CVD);   ST Elevation Myocardial Infarction (STEMI);   Non-ST Elevation Myocardial Infarction (nSTEMI);   Myocardial Infarction Not Otherwise Specified (MI NOS)
Intervention:
11 Completed Subclinical Thyroid Dysfunction and Risk of Myocardial Infarction and Stroke
Conditions: Cardiovascular Diseases;   Heart Diseases;   Hypothyroidism;   Myocardial Infarction;   Cerebrovascular Accident
Intervention:
12 Active, not recruiting Insulin Resistance Intervention After Stroke Trial
Conditions: Stroke;   Myocardial Infarction;   Diabetes
Interventions: Drug: pioglitazone;   Drug: placebo
13 Unknown  A Postmarketing Study of the Risk of Venous Thromboembolism (Blood Clots), Myocardial Infarction (Heart Attacks), and Stroke Among Women Using ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared With Women Who Take Oral Contraceptives for Birth Control
Conditions: Contraception;   Female Contraception
Interventions: Drug: Transdermal Contraceptive System;   Drug: Norgestimate-containing oral contraceptives with EE
14 Recruiting A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure
Conditions: Heart Failure;   Coronary Artery Disease
Interventions: Drug: Rivaroxaban;   Drug: Placebo;   Other: Standard of care for heart failure and coronary artery disease
15 Completed
Has Results
Renin-angiotensin-aldosterone System Polymorphisms in Resistant Hypertension and Adverse Cardiovascular Events
Conditions: Systemic Arterial Hypertension;   Hypertension Resistant to Conventional Therapy;   Myocardial Infarction;   Stroke
Intervention: Drug: Anti-hypertensive drug treatment
16 Unknown  Postmarketing Study of ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) in Relation to Venous Thromboembolism (Blood Clots), Stroke and Heart Attacks
Conditions: Contraception;   Female Contraception
Interventions: Drug: Monophasic or triphasic Oral contraceptive tablet;   Drug: Ortho Evra transdermal patch containing 6 mg NGMN/0.75 mg EE
17 Completed
Has Results
An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome
Conditions: Acute Coronary Syndrome;   Myocardial Infarction;   Myocardial Ischemia;   Unstable Angina
Interventions: Drug: Rivaroxaban 2.5 mg;   Drug: Rivaroxaban 5 mg;   Drug: Placebo;   Drug: Standard of care
18 Completed Risk Factors in the Initial Presentation of Specific Cardiovascular Disease Syndromes
Conditions: Heart Diseases;   Cardiovascular Diseases;   Acute Myocardial Infarction;   Unstable Angina;   Chronic Stable Angina;   Ischemic Stroke;   Cerebrovascular Accident;   Subarachnoid Hemorrhage;   Transient Ischemic Attack;   Abdominal Aortic Aneurysm;   Peripheral Arterial Disease;   Sudden Coronary Death;   Ventricular Arrhythmia;   Sudden Death;   Cardiac Arrest;   Heart Failure
Intervention:
19 Completed Pre-hospital Administration of Thrombolytic Therapy With Urgent Culprit Artery Revascularization
Conditions: Heart Disease;   Myocardial Infarction;   Acute Myocardial Infarction
Interventions: Drug: Retavase 10 U IV Bolus;   Procedure: Angioplasty/Heart Catheterization;   Device: Drug eluting stent placed in heart attack related artery
20 Completed Warfarin After Anterior ST-Elevation Myocardial Infarction
Condition: Myocardial Infarction
Interventions: Drug: aspirin + clopidogrel;   Drug: aspirin + clopidogrel + warfarin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years